L. Gray David - Mar 1, 2024 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Chief Science Officer
Signature
/s/ Christopher Verni, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 05:50 PM
Previous filing
Feb 27, 2023
Next filing
May 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +125K $0.00 125K Mar 1, 2024 Common Stock 125K $3.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and the shares subject to this stock option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2024.